(GBX) Greenbrier Companies - Overview
Sector: IndustrialsIndustry: Railroads | Exchange NYSE (USA) | Currency USD | Market Cap: 1.624m | Total Return -0.8% in 12m
Stock: Railcars, Manufacturing, Leasing, Maintenance
Total Rating 34
Risk 26
Buy Signal -0.92
| Risk 5d forecast | |
|---|---|
| Volatility | 34.3% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -15.23 |
| Character TTM | |
|---|---|
| Beta | 1.117 |
| Beta Downside | 1.490 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.69% |
| CAGR/Max DD | 0.46 |
EPS (Earnings per Share)
Revenue
Description: GBX Greenbrier Companies March 04, 2026
Greenbrier Companies Inc. designs, manufactures, and markets railroad freight car equipment across North America, Europe, and South America.
The company operates in two segments: Manufacturing, and Leasing & Management Services. The Manufacturing segment produces various freight car types, including hopper cars and tank cars, and provides reconditioning services for railcar components. The Leasing & Management Services segment offers operating and per diem leases for a fleet of approximately 17,000 railcars and provides railcar maintenance and fleet management services. The railcar manufacturing sector is cyclical, influenced by freight demand and economic conditions.
Greenbrier serves a diverse client base, including railroads, leasing companies, financial institutions, and shippers. The companys business model combines asset-heavy manufacturing with recurring revenue from leasing and management services.
To gain further insights into GBXs financial performance and industry position, consider exploring its detailed financials on ValueRay.
Headlines to watch out for
- Railcar orders drive manufacturing revenue
- Steel prices impact production costs
- Freight rail traffic affects leasing demand
- Interest rates influence lease financing
- Regulatory changes impact railcar specifications
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 185.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 4.57 > 1.0 |
| NWC/Revenue: 35.47% < 20% (prev 17.76%; Δ 17.71% < -1%) |
| CFO/TA 0.09 > 3% & CFO 402.2m > Net Income 185.2m |
| Net Debt (1.49b) to EBITDA (465.7m): 3.19 < 3 |
| Current Ratio: 3.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.9m) vs 12m ago -1.11% < -2% |
| Gross Margin: 17.34% > 18% (prev 0.17%; Δ 1.72k% > 0.5%) |
| Asset Turnover: 71.41% > 50% (prev 84.11%; Δ -12.70% > 0%) |
| Interest Coverage Ratio: 3.87 > 6 (EBITDA TTM 465.7m / Interest Expense TTM 88.1m) |
Altman Z'' 3.61
| A: 0.25 (Total Current Assets 1.58b - Total Current Liabilities 496.3m) / Total Assets 4.30b |
| B: 0.29 (Retained Earnings 1.23b / Total Assets 4.30b) |
| C: 0.08 (EBIT TTM 340.9m / Avg Total Assets 4.29b) |
| D: 0.47 (Book Value of Equity 1.20b / Total Liabilities 2.56b) |
| Altman-Z'' Score: 3.61 = AA |
Beneish M -0.78
| DSRI: 1.02 (Receivables 527.7m/609.7m, Revenue 3.06b/3.61b) |
| GMI: 0.97 (GM 17.34% / 16.79%) |
| AQI: 5.08 (AQ_t 0.46 / AQ_t-1 0.09) |
| SGI: 0.85 (Revenue 3.06b / 3.61b) |
| TATA: -0.05 (NI 185.2m - CFO 402.2m) / TA 4.30b) |
| Beneish M-Score: -0.78 (Cap -4..+1) = D |
What is the price of GBX shares?
As of March 30, 2026, the stock is trading at USD 51.11 with a total of 161,508 shares traded.
Over the past week, the price has changed by +1.65%, over one month by -9.41%, over three months by +10.56% and over the past year by -0.84%.
Over the past week, the price has changed by +1.65%, over one month by -9.41%, over three months by +10.56% and over the past year by -0.84%.
Is GBX a buy, sell or hold?
Greenbrier Companies has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold GBX.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the GBX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.7 | -2.8% |
| Analysts Target Price | 49.7 | -2.8% |
GBX Fundamental Data Overview March 28, 2026
P/E Trailing = 9.026
P/E Forward = 11.0619
P/S = 0.5291
P/B = 1.007
P/EG = 0.5796
Revenue TTM = 3.06b USD
EBIT TTM = 340.9m USD
EBITDA TTM = 465.7m USD
Long Term Debt = 1.77b USD (from longTermDebt, last quarter)
Short Term Debt = 399.0m USD (from shortTermDebt, last quarter)
Debt = 1.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.49b USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (1.62b + Debt 1.85b - CCE 361.8m)
Interest Coverage Ratio = 3.87 (Ebit TTM 340.9m / Interest Expense TTM 88.1m)
EV/FCF = 25.20x (Enterprise Value 3.11b / FCF TTM 123.4m)
FCF Yield = 3.97% (FCF TTM 123.4m / Enterprise Value 3.11b)
FCF Margin = 4.03% (FCF TTM 123.4m / Revenue TTM 3.06b)
Net Margin = 6.04% (Net Income TTM 185.2m / Revenue TTM 3.06b)
Gross Margin = 17.34% ((Revenue TTM 3.06b - Cost of Revenue TTM 2.53b) / Revenue TTM)
Gross Margin QoQ = 14.63% (prev 18.51%)
Tobins Q-Ratio = 0.72 (Enterprise Value 3.11b / Total Assets 4.30b)
Interest Expense / Debt = 0.89% (Interest Expense 16.4m / Debt 1.85b)
Taxrate = 24.80% (12.3m / 49.6m)
NOPAT = 256.4m (EBIT 340.9m * (1 - 24.80%))
Current Ratio = 3.19 (Total Current Assets 1.58b / Total Current Liabilities 496.3m)
Debt / Equity = 1.20 (Debt 1.85b / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 3.19 (Net Debt 1.49b / EBITDA 465.7m)
Debt / FCF = 12.04 (Net Debt 1.49b / FCF TTM 123.4m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.32% (Net Income 185.2m / Total Assets 4.30b)
RoE = 12.27% (Net Income TTM 185.2m / Total Stockholder Equity 1.51b)
RoCE = 10.41% (EBIT 340.9m / Capital Employed (Equity 1.51b + L.T.Debt 1.77b))
RoIC = 7.84% (NOPAT 256.4m / Invested Capital 3.27b)
WACC = 4.99% (E(1.62b)/V(3.47b) * Re(9.91%) + D(1.85b)/V(3.47b) * Rd(0.89%) * (1-Tc(0.25)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.41%
[DCF] Terminal Value 80.82% ; FCFF base≈123.4m ; Y1≈81.0m ; Y5≈37.0m
[DCF] Fair Price = N/A (negative equity: EV 1.18b - Net Debt 1.49b = -309.5m; debt exceeds intrinsic value)
EPS Correlation: 40.84 | EPS CAGR: -15.47% | SUE: -2.57 | # QB: 0
Revenue Correlation: -17.64 | Revenue CAGR: 0.90% | SUE: 0.73 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.93 | Chg7d=-0.067 | Chg30d=-0.167 | Revisions Net=-2 | Analysts=3
EPS current Year (2026-08-31): EPS=4.12 | Chg7d=-0.050 | Chg30d=+0.067 | Revisions Net=+2 | Growth EPS=-37.5% | Growth Revenue=-10.6%
EPS next Year (2027-08-31): EPS=4.48 | Chg7d=+0.008 | Chg30d=-0.092 | Revisions Net=+0 | Growth EPS=+8.9% | Growth Revenue=+1.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.2% (Discount Rate 9.9% - Earnings Yield 11.1%)
[Growth] Growth Spread = -13.2% (Analyst -14.4% - Implied -1.2%)
P/E Forward = 11.0619
P/S = 0.5291
P/B = 1.007
P/EG = 0.5796
Revenue TTM = 3.06b USD
EBIT TTM = 340.9m USD
EBITDA TTM = 465.7m USD
Long Term Debt = 1.77b USD (from longTermDebt, last quarter)
Short Term Debt = 399.0m USD (from shortTermDebt, last quarter)
Debt = 1.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.49b USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (1.62b + Debt 1.85b - CCE 361.8m)
Interest Coverage Ratio = 3.87 (Ebit TTM 340.9m / Interest Expense TTM 88.1m)
EV/FCF = 25.20x (Enterprise Value 3.11b / FCF TTM 123.4m)
FCF Yield = 3.97% (FCF TTM 123.4m / Enterprise Value 3.11b)
FCF Margin = 4.03% (FCF TTM 123.4m / Revenue TTM 3.06b)
Net Margin = 6.04% (Net Income TTM 185.2m / Revenue TTM 3.06b)
Gross Margin = 17.34% ((Revenue TTM 3.06b - Cost of Revenue TTM 2.53b) / Revenue TTM)
Gross Margin QoQ = 14.63% (prev 18.51%)
Tobins Q-Ratio = 0.72 (Enterprise Value 3.11b / Total Assets 4.30b)
Interest Expense / Debt = 0.89% (Interest Expense 16.4m / Debt 1.85b)
Taxrate = 24.80% (12.3m / 49.6m)
NOPAT = 256.4m (EBIT 340.9m * (1 - 24.80%))
Current Ratio = 3.19 (Total Current Assets 1.58b / Total Current Liabilities 496.3m)
Debt / Equity = 1.20 (Debt 1.85b / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 3.19 (Net Debt 1.49b / EBITDA 465.7m)
Debt / FCF = 12.04 (Net Debt 1.49b / FCF TTM 123.4m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.32% (Net Income 185.2m / Total Assets 4.30b)
RoE = 12.27% (Net Income TTM 185.2m / Total Stockholder Equity 1.51b)
RoCE = 10.41% (EBIT 340.9m / Capital Employed (Equity 1.51b + L.T.Debt 1.77b))
RoIC = 7.84% (NOPAT 256.4m / Invested Capital 3.27b)
WACC = 4.99% (E(1.62b)/V(3.47b) * Re(9.91%) + D(1.85b)/V(3.47b) * Rd(0.89%) * (1-Tc(0.25)))
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.41%
[DCF] Terminal Value 80.82% ; FCFF base≈123.4m ; Y1≈81.0m ; Y5≈37.0m
[DCF] Fair Price = N/A (negative equity: EV 1.18b - Net Debt 1.49b = -309.5m; debt exceeds intrinsic value)
EPS Correlation: 40.84 | EPS CAGR: -15.47% | SUE: -2.57 | # QB: 0
Revenue Correlation: -17.64 | Revenue CAGR: 0.90% | SUE: 0.73 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.93 | Chg7d=-0.067 | Chg30d=-0.167 | Revisions Net=-2 | Analysts=3
EPS current Year (2026-08-31): EPS=4.12 | Chg7d=-0.050 | Chg30d=+0.067 | Revisions Net=+2 | Growth EPS=-37.5% | Growth Revenue=-10.6%
EPS next Year (2027-08-31): EPS=4.48 | Chg7d=+0.008 | Chg30d=-0.092 | Revisions Net=+0 | Growth EPS=+8.9% | Growth Revenue=+1.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.2% (Discount Rate 9.9% - Earnings Yield 11.1%)
[Growth] Growth Spread = -13.2% (Analyst -14.4% - Implied -1.2%)